44 related articles for article (PubMed ID: 38567612)
1. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel aryl-substituted 2-aminopyridine derivatives by the cascade reaction of 1,1-enediamines with vinamidinium salts to develop novel anti-Alzheimer agents.
Loori S; Pourtaher H; Mehranpour A; Hasaninejad A; Eftekharian M; Iraji A
Sci Rep; 2024 Jun; 14(1):13780. PubMed ID: 38877034
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new N-(5,6-methylenedioxybenzothiazole-2-yl)-2-[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE-1 inhibitory activities.
Tutuş B; Kaya AZ; Baz Y; Evren AE; Sağlik Özkan BN; Yurttaş L
Drug Dev Res; 2024 Jun; 85(4):e22214. PubMed ID: 38816986
[TBL] [Abstract][Full Text] [Related]
4. The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening.
Gambardella MD; Wang Y; Pang J
Molecules; 2024 May; 29(10):. PubMed ID: 38792196
[TBL] [Abstract][Full Text] [Related]
5. Discovery, Structure-Based Modification,
Lu X; Li Y; Guan Q; Yang H; Liu Y; Du C; Wang L; Wang Q; Pei Y; Wu L; Sun H; Chen Y
ACS Chem Neurosci; 2024 Mar; 15(6):1135-1156. PubMed ID: 38453668
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An
Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ
Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases and the fine line between poison and remedy.
Pope CN; Brimijoin S
Biochem Pharmacol; 2018 Jul; 153():205-216. PubMed ID: 29409903
[TBL] [Abstract][Full Text] [Related]
8. Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022.
Murray AP; Biscussi B; Cavallaro V; Donozo M; Rodriguez SA
Curr Neuropharmacol; 2024; 22(10):1621-1649. PubMed ID: 37357520
[TBL] [Abstract][Full Text] [Related]
9. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
Moss DE; Perez RG
Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
[TBL] [Abstract][Full Text] [Related]
10. Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.
Egbujor MC
Cent Nerv Syst Agents Med Chem; 2024; 24(1):82-104. PubMed ID: 38275073
[TBL] [Abstract][Full Text] [Related]
11. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.
Mugnaini C; Brizzi A; Paolino M; Scarselli E; Castelli R; de Candia M; Gambacorta N; Nicolotti O; Kostrzewa M; Kumar P; Mahmoud AM; Borgonetti V; Iannotta M; Morace A; Galeotti N; Maione S; Altomare CD; Ligresti A; Corelli F
ACS Chem Neurosci; 2024 Mar; 15(5):955-971. PubMed ID: 38372253
[TBL] [Abstract][Full Text] [Related]
12. Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies.
Pant S; Kumar K R; Rana P; Anthwal T; Ali SM; Gupta M; Chauhan M; Nain S
ACS Chem Neurosci; 2024 Feb; 15(4):783-797. PubMed ID: 38320262
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin IA; Nurmaganbetov ZS; Fazylov SD; Nurkenov OA; Khlebnikov AI; Seilkhanov TM; Kishkentaeva AS; Shults EE; Quinn MT
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110594
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of newly synthesized benzimidazole derivative for anti-Alzheimer potential.
Ahmed A; Khan AU; Nadeem H; Imran M; Irshad N
Int J Neurosci; 2024 Jun; 134(6):635-651. PubMed ID: 36259511
[No Abstract] [Full Text] [Related]
15. Molecular docking and dynamics simulation approach of
Hosen ME; Rahman MS; Faruqe MO; Khalekuzzaman M; Islam MA; Acharjee UK; Zaman R
In Silico Pharmacol; 2023; 11(1):14. PubMed ID: 37255739
[TBL] [Abstract][Full Text] [Related]
16. Computational identification of potential acetylcholinesterase (AChE) and monoamine oxidase-B inhibitors from
Sofela SO; Ibrahim A; Ogbodo UC; Bodun DS; Nwankwo DO; Mafimisebi M; Abdulrasheed B; Balogun T; Opeyemi I
In Silico Pharmacol; 2024; 12(1):49. PubMed ID: 38828442
[TBL] [Abstract][Full Text] [Related]
17. In Silico Discovery and Predictive Modeling of Novel Acetylcholinesterase (AChE) Inhibitors for Alzheimer's Treatment.
Suha HN; Hossain MS; Rahman S; Alodhayb A; Hossain MM; Kawsar SMA; Poirier R; Uddin KM
Med Chem; 2024 May; ():. PubMed ID: 38803179
[TBL] [Abstract][Full Text] [Related]
18. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands.
Sun T; Zhen T; Harakandi CH; Wang L; Guo H; Chen Y; Sun H
Eur J Med Chem; 2024 Jun; 275():116569. PubMed ID: 38852337
[TBL] [Abstract][Full Text] [Related]
19. Assessment of
Biswas K; Azad AK; Sultana T; Khan F; Hossain S; Alam S; Chowdhary R; Khatun Y
J Intercult Ethnopharmacol; 2017; 6(1):115-120. PubMed ID: 28163969
[TBL] [Abstract][Full Text] [Related]
20. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection.
Sharma M; Pal P; Gupta SK
Neurochem Int; 2024 Jul; 177():105761. PubMed ID: 38723902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
